Think Research (TSXV:THNK) ROCE % : -18.98% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Think Research ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Think Research's annualized ROCE % for the quarter that ended in Sep. 2023 was -18.98%.

Think Research ROCE % Historical Data

The historical data trend for Think Research's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Think Research ROCE % Chart

Think Research Annual Data

Trend

Sep20

Dec21

Dec22

ROCE %

-62.77

-29.72

Think Research Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial								-29.35	-28.01	-15.97	-9.36	-18.98

Think Research ROCE % Calculation

Think Research's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-23.928	/	( ( (137.106 - 39.03)	+	(122.879 - 59.945) )	/ 2 )
	=	-23.928	/	( (98.076	+	62.934)	/ 2 )
	=	-23.928	/	80.505
	=	-29.72 %

Think Research's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-13.284	/	( ( (118.623 - 33.497)	+	(114.655 - 59.789) )	/ 2 )
	=	-13.284	/	( ( 85.126	+	54.866 )	/ 2 )
	=	-13.284	/	69.996
	=	-18.98 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Think Research (TSXV:THNK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Think Research ROCE % Related Terms

Thank you for viewing the detailed overview of Think Research's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Think Research (TSXV:THNK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Think Research Corp (TSXV:THNK) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

THKKF:USA

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.thinkresearch.com

Think Research Corp and its subsidiaries are a healthcare technology company digitalizing the delivery of knowledge to facilitate better healthcare outcomes. The company gathers, develops, and delivers a knowledge-based Software-as-a-Service solution globally to customers which typically includes enterprise clients, hospitals, health regions, healthcare professionals, and/or governments. Its cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care, including primary physician care, acute care hospitals and surgical suites as well as community and senior care.

Executives

Christopher Collenette	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Patrick Craib	Senior Officer
John Hayes	Senior Officer
Anna Taylor	Senior Officer

Think Research (TSXV:THNK) Headlines

No Headlines